학술논문
Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.
Document Type
Article
Author
Source
Neoplasma; 2021, Vol. 68 Issue 3, p626-630, 5p
Subject
Language
ISSN
00282685
Abstract
Copyright of Neoplasma is the property of AEPress s.r.o. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)